首例经单一微创入路同期行二尖瓣置换与冠状动脉旁路移植术
本文报告一例78岁女性,因冠心病及左心室和瓣环扩张导致的继发性重度二尖瓣反流,经心脏团队推荐行同期微创直接冠状动脉旁路移植联合经心尖二尖瓣置换(Tendyne瓣膜),经同一切口完成。术后第8天经胸超声显示瓣膜功能良好,平均跨瓣压差2 mmHg,无左心室流出道梗阻,射血分数稳定为50%。作者认为该联合术式可行,是向微创治疗迈进的一步。
要点
- 首例经单一微创入路同期行微创直接冠状动脉旁路移植与经心尖二尖瓣置换。
- 术后第8天超声示瓣膜功能良好,平均跨瓣压差2 mmHg,射血分数50%。
- 作者认为该联合术式可行,是向微创治疗迈进的一步。
核心结论
- 微创直接冠状动脉旁路移植联合经心尖二尖瓣置换的联合术式可行,是向微创治疗迈进的一步,即使在复杂情况下也可行。
研究设计与样本
- 本文为病例报告,报告一例78岁女性患者,因冠心病及左心室和瓣环扩张导致的继发性重度二尖瓣反流,经心脏团队推荐行同期微创直接冠状动脉旁路移植联合经心尖二尖瓣置换(Tendyne瓣膜),经同一切口完成。
主要发现
- 手术在杂交手术室由心脏外科医生与心脏内科医生紧密协作完成,术中及术后过程平稳。
- 术后第8天出院前经胸超声心动图显示植入瓣膜功能良好,无瓣周或跨瓣反流,平均跨瓣压差2 mmHg,无左心室流出道梗阻,射血分数稳定为50%。
临床怎么用
- 作者认为,微创直接冠状动脉旁路移植血运重建联合同期经心尖二尖瓣置换可行,是向微创治疗迈进的一步,即使在复杂情况下也可行。
- 作者认为,现代心脏团队模式超越了单纯的决策制定,并扩展为对患者的杂交治疗。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
We present the case of a 78-year-old woman suffering from coronary artery disease and secondary severe mitral valve regurgitation due to left ventricular and annular distention. The interdisciplinary heart team recommended a simultaneous hybrid procedure consisting of minimally invasive direct coronary artery bypass grafting with subsequent transapical mitral valve replacement using the Tendyne prosthesis via the same small anterolateral thoracotomy. The operation was performed using a heart-team approach with close collaboration between heart surgeons and cardiologists in the hybrid operating theatre. The intra- and postoperative courses were uneventful. Predischarge transthoracic echocardiography on postoperative day 8 revealed the immaculate functioning of the implanted valve without para- or transvalvular insufficiency, a mean gradient of 2 mmHg, no left ventricular outflow tract obstruction and a stable ejection fraction of 50%. The combination of minimally invasive direct coronary artery bypass grafting revascularization with concomitant transapical mitral valve replacement is feasible and enables a further step towards minimally invasive therapy, even in complex situations. It shows that the modern heart-team approach exceeds mere decision making and expands towards a hybrid treatment for patients.
引用
- Miazza J, Koechlin L, Jeger RV, et al. First-in-man concomitant mitral valve replacement and coronary artery bypass grafting using a single minimally invasive access. Eur J Cardiothorac Surg. 2022. PMID: 35678570. doi:10.1093/ejcts/ezac330
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。